Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT04162015 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

A Study of Nivolumab and Chemotherapy Followed by Surgery for Mesothelioma

Name: A Study of Nivolumab and Chemotherapy Followed by Surgery for Mesothelioma — clinical trial record (NCT04162015)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

StatusActive, Not Recruiting

PhasePhase 1

SponsorMemorial Sloan Kettering Cancer Center

Started2019-11-12

View on ClinicalTrials.gov ↗

This study will test whether giving nivolumab in combination with pemetrexed and either cisplatin or carboplatin before surgery is a safe and effective approach to treating resectable mesothelioma without delaying surgery.

Amendment history 2 changes detected by DataLookout

2026-09-12

Primary completion pushed: 2026-11 → 2027-11

2026-09-12

Completion pushed: 2026-11 → 2027-11

Trial Details

NCT Number	NCT04162015
Lead Sponsor	Memorial Sloan Kettering Cancer Center Collaborators: Bristol-Myers Squibb
Conditions	Malignant Pleural Mesothelioma
Enrollment	22 participants
Start Date	2019-11-12
Primary Completion	2027-11 (estimated)
Study Completion	2027-11 (estimated)
Updated on ClinicalTrials.gov	2026-09-11